BioCentury | Feb 15, 2019
Company News

ZappRx, Teva partner to increase patient access to specialty respiratory drugs

...performance. Teva Pharmaceutical markets multiple specialty drugs for chronic obstructive pulmonary disease and asthma including Aerivio Spiromax...
...Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA), Petach Tikva, Israel Business: Pulmonary, Inflammation Hongjiang Li Aerivio Spiromax, AirDuo RespiClick, Airexar Spiromax, fluticasone propionate/salmeterol Teva...
BioCentury | Jul 11, 2016
Clinical News

Fluticasone propionate/salmeterol regulatory update

...FDA accepted for review NDAs from Teva for fluticasone propionate and fluticasone propionate/salmeterol delivered via the RespiClick...
...ADRB2 ) agonist (LABA). Separately, EMA’s CHMP recommended approval of the combination therapy as Aerivio Spiromax/Airexar Spiromax...
...disorder (COPD). Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Product: Fluticasone propionate/salmeterol ( Airexar Spiromax , Aerivio Spiromax...
BioCentury | Nov 23, 2015
Clinical News

Fluticasone propionate/salmeterol MDPI: Phase III data

...symptomatic despite low- or mid-dose inhaled corticosteroid therapy showed that twice-daily 50/12.5 and 100/12.5 ug fluticasone propionate/salmeterol...
...met the primary endpoint of improving trough FEV1 from baseline to week 12 vs. placebo. Fluticasone propionate/salmeterol...
...in the U.S. for both products. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Product: Fluticasone propionate/salmeterol...
BioCentury | Nov 23, 2015
Clinical News

Fluticasone propionate MDPI: Phase III data

...symptomatic despite low- or mid-dose inhaled corticosteroid therapy showed that twice-daily 50/12.5 and 100/12.5 ug fluticasone propionate/salmeterol...
...met the primary endpoint of improving trough FEV1 from baseline to week 12 vs. placebo. Fluticasone propionate/salmeterol...
BioCentury | Nov 23, 2015
Clinical News

Fluticasone propionate MDPI: Phase III data

...asthma that was symptomatic despite inhaled corticosteroid therapy showed that twice-daily 100/12.5 and 200/12.5 ug fluticasone propionate/salmeterol...
...area under the curve (AUC) over 0-12 hours from baseline to week 12 vs. placebo. Fluticasone propionate/salmeterol...
BioCentury | Nov 23, 2015
Clinical News

Fluticasone propionate MDPI: Phase III data

...1,087 adolescent and adult patients with persistent asthma showed that twice-daily 100/12.5 and 200/12.5 ug fluticasone propionate/salmeterol...
BioCentury | Nov 23, 2015
Clinical News

Fluticasone propionate/salmeterol MDPI: Phase III data

...asthma that was symptomatic despite inhaled corticosteroid therapy showed that twice-daily 100/12.5 and 200/12.5 ug fluticasone propionate/salmeterol...
...area under the curve (AUC) over 0-12 hours from baseline to week 12 vs. placebo. Fluticasone propionate/salmeterol...
...in the U.S. for both products. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Product: Fluticasone propionate/salmeterol...
BioCentury | Nov 23, 2015
Clinical News

Fluticasone propionate/salmeterol MDPI: Phase III data

...1,087 adolescent and adult patients with persistent asthma showed that twice-daily 100/12.5 and 200/12.5 ug fluticasone propionate/salmeterol...
...in the U.S. for both products. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Product: Fluticasone propionate/salmeterol...
BioCentury | Nov 20, 2015
Clinical News

Teva's inhalers meet in Phase III asthma studies

...Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) said two multidose dry powder inhalers, fluticasone propionate/salmeterol MDPI formulation and fluticasone...
...regulatory applications for the treatments in 2016. Teva spokesperson Michelle Larkin told BioCentury that both fluticasone propionate/salmeterol...
BioCentury | Oct 6, 2014
Clinical News

Fluticasone propionate/salmeterol xinafoate: Phase III start

...a double-blind, placebo-controlled, U.S. Phase III trial to compare bioequivalence of inhaled MGR001 vs. Advair fluticasone propionate/salmeterol...
...inhaler delivery platform. Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Pfizer Inc. (NYSE:PFE), New York, N.Y. Product: Fluticasone propionate/salmeterol...
Items per page:
1 - 10 of 38